Darmadi, D., Sungkar, T., Pakpahan, C., & Surja, S. S. (2024). An Efficacy and Safety Comparison of Regorafenib and Nivolumab in Unresectable Hepatocellular Cancer Patients: A Systematic Review. Acta Medica Academica, 53(1), 46–58. https://doi.org/10.5644/ama2006-124.443